(Q48339041)

10 February 2018

reason for preferred rank

title

Characteristic developmental expression of amyloid β40, 42 and 43 in patients with Down syndrome (English)

1 reference

https://api.crossref.org/works/10.1016/S0387-7604(02)00209-7

23 December 2023

Characteristic developmental expression of amyloid beta40, 42 and 43 in patients with Down syndrome (English)

1 reference

PubMed ID

12689696

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12689696

23 December 2023

author name string

Aya Hirayama

1

1 reference

10 February 2018

Yuko Horikoshi

2

1 reference

10 February 2018

Masahiro Maeda

3

1 reference

10 February 2018

Masayuki Ito

4

1 reference

10 February 2018

Sachio Takashima

5

1 reference

10 February 2018

language of work or name

English

1 reference

National Center for Biotechnology Information

PubMed ID

12689696

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12689696

23 December 2023

publication date

1 April 2003

1 reference

10 February 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S0387760402002097?httpAccept=text/xml

1 reference

DOI

https://api.crossref.org/works/10.1016/S0387-7604(02)00209-7

https://api.elsevier.com/content/article/PII:S0387760402002097?httpAccept=text/plain

23 December 2023

1 reference

DOI

https://api.crossref.org/works/10.1016/S0387-7604(02)00209-7

23 December 2023

published in

Brain and Development

1 reference

10 February 2018

volume

25

1 reference

10 February 2018

issue

3

1 reference

10 February 2018

page(s)

180-185

1 reference

10 February 2018

Abnormal neuronal development in the visual cortex of the human fetus and infant with down's syndrome. A quantitative and qualitative Golgi study.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2802%2900209-7

7 January 2021

Molecular mapping of Alzheimer-type dementia in Down's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2802%2900209-7

7 January 2021

Developmental and aging changes in the expression of amyloid precursor protein in Down syndrome brains.

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2802%2900209-7

7 January 2021

Amyloid plaque core protein in Alzheimer disease and Down syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2802%2900209-7

7 January 2021

The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2802%2900209-7

7 January 2021

Amyloid beta protein 1-42/43 (A beta 1-42/43) in cerebellar diffuse plaques: enzyme-linked immunosorbent assay and immunocytochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2802%2900209-7

7 January 2021

Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43).

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2802%2900209-7

7 January 2021

Amyloid beta protein (A beta) deposition: A beta 42(43) precedes A beta 40 in Down syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2802%2900209-7

7 January 2021

Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2802%2900209-7

7 January 2021

Intraneuronal Abeta42 accumulation in human brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2802%2900209-7

7 January 2021

Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation.

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2802%2900209-7

7 January 2021

Reverse relationship between beta-amyloid precursor protein and beta-amyloid peptide plaques in Down's syndrome versus sporadic/familial Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2802%2900209-7

7 January 2021

Identifiers

DOI

1 reference

10 February 2018

PubMed ID

12689696

1 reference

10 February 2018